Five brain-derived and 17 urinary oligomannose-type oligosaccharides were isolated by ion-exchange chromatography on Mono Q or Dowex, tbllowed by HPLC on Lichrosorb-NH 2 from a Persian cat suffering from ~-mannosidosis. The structures of the carbohydrate chains were determined by 500-or 600-MHz 1H-NMR spectroscopy. Different oligosaccharide patterns were found in brain and urine. 99% of the urinary oligosaccharides possess an c~(1-6)-Iinked mannose residue attached to fi-mannose, whereas only 5% of the brain-derived oligosaccharides contain such a residue. Furthermore, of the urinary carbohydrate chains 71~ end with Manfll-4GlcNAcfil-4GlcNAc and 29~ end with Manfil-4GlcNAc, whereas the corresponding amounts are 23% and 77%, respectively, for the brain-derived oligosaccharides.
e-Mannosidosis is a lysosomal storage disease resulting from a deficiency in lysosomal acidic c~-D-mannosidase(s) (EC 3.2.1.24) [1] . The disease is characterized by the massive accumulation in cells and excretion in urine of mannose-rich otigosaccharides. The first case of ~-mannosidosis was described in man [2] , and afterwards in cattle [3] and cats [4] . A similar condition can also be induced in animals by ingestion of plants containing the ct-mannosidase inhibitor swainsonine [5, 6] .
Biochemically, feline ~-mannosidosis shows both similarities to and differences from bovine and human e-mannosidosis [7] . Clinically, the extent and the appearance of the cells resemble more closely those in the severe human variant than those in the bovine disease [7] . Therefore, feline a-mannosidosis is a useful animal model for studying the human disease [8] . The accumulated oligosaccharides in different tissues in feline c~-mannosidosis have been the * To whom correspondence should be addressed.
0282-0080/91 $03.00+.12 © 1991 Chapman and Hall Ltd subject of several investigations [9] [10] [11] [12] . Oligosaccharides from feline ~-mannosidosis brain have been partially characterized by chromatographic profiling, but no detailed structural work has been carried out [10] . The present study was undertaken to characterize the brain-derived oligosaccharides from a recently identified case of feline ~-mannosidosis [13, 14] . For comparison, also the urinary oligosaccharides were studied. The results reported here differ significantly from those obtained by chromatographic profiling [10] .
Materials and methods

Isolation of oli9osaccharides fi'om urine and brain
Urine (4 ml) of the cat was passed through a column (5 x 2 cm) containing equal layers of AG 50W-X8 (H +-form, Bio-Rad, Richmond, CA, USA) and AG I-X8 (acetateform) equilibrated in water. The column was eluted with water and 10 ml fractions were collected. Carbohydratecontaining fractions, as indicated by orcinol/H2SO4 staining, were combined and evaporated to dryness.
Brain tissue (7 g wet weight) of the cat was cut into small pieces and homogenised with two volumes of water for 5 min at 4°C with a Potter-Elvehjem blender. After three freeze-thaw cycles and sonication for two periods of 30 s (Soniprep 150 MSE) at 4°C, the homogenate was centrifuged at 5000 x g for 15 min at 25°C. The supernatant was concentrated to 4 ml by rotary evaporation and passed through a column (180 x 1 cm) of Bio-Gel P-10 (200-400 mesh, Bio-Rad). The column was eluted with water, containing 0.02% (by weight) sodium azide, and 2 ml fractions were collected. Carbohydrate-containing fractions were identified by anthrone/ H2SO 4 staining [15] , pooled, concentrated, and applied to a column (180 x 1 cm) of Bio-Gel P-2 (200-400 mesh, Bio-Rad) eluted with water. Carbohydrate-positive fractions were combined and evaporated to dryness.
Anion-exchange chromatography of the mixture of brainderived oligosaccharides was performed on a Mono Q HR 5/5 column (50 x 5 ram, Pharmacia, Sweden) connected to a Fast Protein Liquid Chromatography (FPLC) apparatus (Pharmacia) equipped with two P-500 pumps and a LCC-500 control unit. The sample was dissolved in 1.0 ml water and 200 lal aliquots were injected. Elution of the sample was performed with 2 ml water followed by a linear gradient of 0-50 mM NaC1 in 8 ml water, and finally followed by a steeper gradient from 50-500 mM NaC1 in 10 ml water at a flow rate of lmlmin 1. The eluate was monitored at 214 nm using a Pharmacia UV-1 detector. Carbohydratecontaining fractions were identified by orcinol/H2SO4 staining, combined and evaporated to dryness.
HPLC
HPLC was carried out with a Kratos SF 400 system (ABI Analytical, Kratos Division, USA) equipped with a Lichrosorb-NH 2 10 gm column (250 x 4.6 mm, Chrompack, The Netherlands). The pool of urinary oligosaccharides was separated isocratically with water/acetonitrile, 35/65 by vol, at a flow rate of 1.5 ml min -1. The pool of brain-derived oligosaccharides was fractionated isocratically with water/ acetonitrile, 25/75 by vol, at a flow rate of 1 ml min-1. The eluate was monitored by a Spectroflow 757 variable-wavelength recorder (ABI Analytical, Kratos Division) at 195 nm (brain-derived oligosaccharides) or 205 nm (urinary oligosaccharides). The molar ratio of oligosaccharides is determined on the basis of HPLC peak areas (corrected for the number of N-acetyl groups) [16] . For HPLC peaks containing more than one oligosaccharide, the 1H-NMR spectra have also been used for determination of relative amounts of oligosaccharides.
and 600 MHz 1H-NMR spectroscopy
Oligosaccharides were repeatedly exchanged in 2H20 (99.96 atom-% 2H, Aldrich, USA) with intermediate lyophilization.
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Resolution-enhanced IH-NMR spectra were recorded on a Bruker AM-500 spectrometer (Department of Chemistry, Utrecht University) or a Bruker AM-600 spectrometer (SON hf-NMR facility, Department of Biophysical Chemistry, Nijmegen University, The Netherlands) operating at 500 and 600 MHz, respectively, at probe temperatures of 27°C. Chemical shifts (5) are expressed in ppm relative to internal acetone in 2H20 (6 = 2.225 ppm) [17] . The twodimensional homonuclear Hartmann-Hahn (2D HOHAHA) experiments were performed with a MLEV-17 mixing sequence [t8], with total mixing times of 20 100 ms. Usually about 400 free-induction decays of 2 k data points, 32-96 scans each (depending on the amount of the respective sample), were collected. The 90 ° 1H-pulse width was adjusted to 25-30 gs and the residual HO2H signal was suppressed by presaturation during 1 s. The time-proportional phase incrementation (TPPI) was used for the ttamplitude modulation [19] .
Results
The oligomannose-type oligosaccharides isolated from the urine and the brain of the cat suffering from c~-mannosidosis can be divided into two groups. Group A contains oligosaccharides ending with Manfil-4GlcNAc, and group B comprises oligosaccharides ending with Manfil-4GlcNAcflt-4GlcNAc. The presence of GlcNAc or N,N'-diacetylchitobiose at the reducing end can readily be deduced from characteristic structural-reporter-group signals in the 1H-NMR spectrum of the corresponding oligosaccharide. Relevant 1H-NMR parameters for the manno-oligosaccharides isolated in the present study are compiled in Tables 1 (compounds of group A) and 2 (compounds of group B). For oligosaccharides of group A the H-1 c~ signal of GlcNAc-2 resonates at 6 = 5.205-5.210 ppm and the NAc protons at 6 = 2.041-2.044 ppm, provided that Man-3 is unsubstituted at C-6 (for numbering of the monosaccharide residues, see Fig. 1 ) [17] . If Man-3 is substituted at C-6 and Man-4' is unsubstituted at C-3, the H-I~ doublet of GlcNAc-2 is observed at 5 = 5.212-5.216 ppm and the NAc singlet at 5 = 2.054 2.061 ppm. The GlcNAc-2 H-le signal resonates at 5 = 5.23-5.25 ppm and the NAc-protons resonate at
Figure 1. Numbering of the monosaccharide residues in an oligomannose-type otigosaccharide. b Some chemical shift values are given with only two decimals because of spectral overlap. ~ and [t stand for the ct-and/#anomers, respectively, of GIcNAc-2. Table 2 . JH-chemical shifts of structural-reporter-group portons of the constituent monosaccharides for the oligosaccharides with the Manfll-4GlcNAc//1-4GlcNAc element in common, derived from urine and brain of the c~-mannosidosis cat. Chemical shifts, measured at 27°C in 2H20 , are given in ppm relative to internal acetone (6 = 2.225 ppm).
Compounds are represented by shorthand symbolic notation [17] : O, GIcNAc; ~, Man. For numbering of the monosaceharide residues see Fig. 1 . 
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Man-D3 [20] that a linear relationship is obtained when plotting the logarithm of the retention time on a HPLC NH~-column against the number of mannose residues. In this way the number of mannose residues of a compound having the general formula Man;GtcNAcj (i = 1-9,j = 1-2) can be predicted. Compounds having one or two Nacetylglucosamine residues fall on two different lines. This information was used in the present study for those HPLC fractions which contain more than one component.
Oligosaccharides .from urine
Neutral oligosaccharides were isolated from the urine of the affected cat by ion-exchange chromatography on Dowextype cation-and anion-exchange resins. The carbohydratecontaining fractions were combined and separated by HPLC on Lichrosorb-NH 2. The HPLC analysis revealed the presence of nine carbohydrate positive fractions, denoted U1-U9 (Fig. 2) . These fractions were analysed by 1H-NMR spectroscopy.
Fraction UI. The 1H-NMR spectrum of fraction U1 shows the presence of two oligosaccharides in a molar ratio of approximately 2:1 (spectrum not shown). spectrum of U1 was recorded with a 40 ms mixing time (spectrum not shown). This experiment proved the H-l/H-2 connectivities for the terminal mannose residues. The structural-reporter groups of U1.2 fit the 1H-NMR data of the terminal structural element Manc~l-6Man/~l-4GlcNAc, present in glycoasparagines isolated from the urine of patients with aspartylglucosaminuria and Gaucher's disease (cf. compound 3 in [17] Fraction U2. The 1H-NMR spectrum of fraction U2 shows one major component (U2.1) constituting about 90~o of this fraction (spectrum not shown). The structure of this compound is Manel-6Manrql-4GlcNAc/~l-4GlcNAc. The presence of a N,N'-diacetylchitobiose unit at the reducing end is deduced from the typical GlcNAc H-t and NAc signals (see Table 2 ). Fraction U4. The 1H-NMR spectrum of fraction U4 (Fig.   3 ) shows one component (U4), being the most abundant (52~o) oligosaccharide in the urine. The chemical shift values of the H-1 and H-2 signals of Man-3, -4, and -4' establish the branching pattern and the structure at the non-reducing end of this oligosaccharide to be identical to that in compound U3. However, in contrast to U3 oligosaccharide U4 contains an intact N,N'-diacetylchitobiose unit at the reducing end, evidenced by the typical H-1 and NAc signals of GlcNAc-I and -2 (see Table 2 ). Thus the structure of U4 is Mancd-3(Manal-6)Manfil-4GlcNAc~l-4GlcNAc. The chemical shift values of the structural-reporter-group protons for U4 match completely those previously reported for a similar oligosaccharide prepared by exo-and endo-glycosidase digestions of a Pronase digest of Cohn's fraction IV (cf. compound B in [22] ).
Fraction U5. The 1H-NMR spectrum of fraction U5 (spectrum not shown) shows one major (85~) component (U5). The minor (15°./o) component stems from the closely eluting preceding larger fraction U4. The GlcNAc H-1 and NAc values indicate that compound U5 contains GlcNAc-2 at the reducing end (see Table 1 ). The H-1 and H-2 signals of Man-4' are characteristic for this residue in terminal position. As compared to U3, the additional ~-anomeric signal at 6 = 5.051 ppm in U5 is assigned to a terminal ~(1-2)-tinked Man-C residue. This is supported by the lowfield position of Man-4 H-1 at 6 = 5.352 ppm [17] , affording the structure Manel-2Man~l-3(Mancd-6)Man/31-4GlcNAc for U5. An identical oligosaccharide isolated from swainsonine-intoxicated sheep has previously been analysed as alditol by 1H-NMR spectroscopy (cf. compound Man~GlcNAc in [20] Fraction U6. Fraction U6 was collected in two parts, denoted U6A and U6B, respectively. The relative elution times on HPLC indicate that these fractions contain compounds having the general formula Man~GlcNAc 2. The 1H-NMR spectra of these fractions indicate a large heterogeneity (spectra not shown). However, in both fractions the same signals are present, the only difference being their relative intensities. For this reason the 1H-NMR spectrum of the fraction containing larger amounts of material (U6A) was used for the structure determination. Because of the heterogeneity of this fraction a 2D HOHAHA spectrum with a 76 ms mixing time was recorded, and all Man H-l/H-2 connectivities were deduced from this spectrum. From the 1H-NMR data of fraction U6 the structure of four isomeric Man4GtcNAc z oligosaccharides could be established. The N,N'-diacetylchitobiose unit at the reducing end is confirmed by the H-1 and NAc signals of GlcNAc-1 and -2 (see Table 2 ). An e-anomeric mannose signal at c5 = 5.10 ppm together with the H-2 resonance at 6 = 4.07 ppm is typical for terminal e(1-3)-linked mannoses (Man-4 and Man-A). In combination with the characteristic set of signals for the terminal element Manel-3Manel-6Man/~ (see the H-1 and H-2 signals of Man-A and -4', cf. compound 66 in [17] , and the NAc signal of GlcNAc-2 for compound U6.1 in Table  2 ), and the fact that the Man-4' H-1 signal of highest intensity is the one belonging to the mono-3-substituted Man-4' residue, the most abundant otigosaccharide (U6.1) in fraction U6 is deduced to be Manel-3(Manc~l-3Man c~l-6(Man/~l-4GlcNAc//1-4GlcNAc.
A signal at 6 = 5.349 ppm (Man-4 H-t) together with a signal at 6 = 5.051 ppm (Man-C H-l) indicate a compound having the terminal sequence Manel-2Manel-3Man/~ (cf. compound 66 in [17] ). In combination with a signal of comparable intensity at c5 = 4.916 ppm (coupled to a H-2 signal at ~5 = 3.97 ppm), being typical for a terminal ~(1-6)-linked Man-4', and a NAc signal at 6 = 2.078 ppm, characteristic for GlcNAc-2 when Man-4' is unsubstituted, compound U6.2 in fraction U6 is deduced to be Man M-2Mane 1-3(Mane 1-6)Man/31-4GlcNAc/31-4GlcNAc.
In the ~H-NMR spectrum of fraction U6 there are also signals of comparable intensity at ~ = 5.144 ppm and 3 = 5.042 ppm. These signals are assigned to Man-B and Man-D 3 in the terminal sequence Mancd-2Mancd-6Manc~ (D 3-B-4'-, cf. compound 67 in [17] ), affording the following structure: Manel -2Manel -6Manel -6Man/~l -4GlcNAc flt-4GlcNAc (U6.3).
Finally, the e-anomeric Man H-1 signal at c~ = 4.870 ppm, coupled to a H-2 signal at c5 = 4.13 ppm, is typical for a 3,6-disubstituted Man-4' residue, yielding the following Fraction U7. Fraction U7 was collected in two parts, denoted U7A and U7B. The relative elution times on HPLC indicate that these fractions contain compounds having the general formula MansGlcNAc. From the GlcNAc H-1 and NAc signals it is obvious that all carbohydrate chains in fractions U7A and U7B have GlcNAc-2 at the reducing end (see Table 1 ). The 1H-NMR spectrum of fraction U7A shows five ~-anomeric signals of equal intensity at 5 = 5.212 ppm (c~GlcNAc-2), 5 = 5.345 ppm (Man4, 2-substituted), 5 = 5.303 ppm (Man-C, 2-substituted), 6 = 5.043 ppm (Man-D1), and 5 = 4.9t7 ppm (Man-4', unsubstituted) (spectrum not shown). Thus the structure of this major compound (U7.1) of fraction U7 is Mancd-2Mancd-2Mancd-3(Man ~l-6)Manfll-4GlcNAc. Oligosaccharide U7.1 accounts for about 90% of the carbohydrate chains in fraction U7A; the remaining 10% is due to overlap with U7B.
The anomeric region of the 500 MHz 1H-NMR spectrum of fraction U7B is shown in Fig. 4 . In addition to signals belonging to compound U7.1, an c~GlcNAc-2 H-1 signal is present at 5 = 5.248 ppm, indicative of Man-A c~(1-3)-linked to . This is supported by the H-1 signals at 6 = 5.080 ppm (Man-A, when GlcNAc-2 is ~) and 5 = 5.101 ppm (Man-A, when GlcNAc-2 is fi). The chemical shift value of Man-4' (5 = 4.873 ppm) points to a disubstituted Man-4' residue, confirmed by the H-t signal of Man-B at = 4.914ppm. A terminal Man-4 is recognized by the combination of a H-1 signal at 6 = 5.101 ppm and a H-2 signal at 6 = 4.08 ppm. In conclusion, the proposed structure for the major component in fraction U7B is Man cd-3(Mancd-6)Maned-6(Maned-3)Manfil-4GlcNAc (U7.2). Figure 4 . The ~-anomeric region of the resolution-enhanced 500-MHz tH-NMR spectrum of the mixture of oligosaccharides UT.1 and U7.2 (fraction UTB), together with the H-l/H-2 cross-peaks from the 2D HOHAHA spectrum, which was recorded with a 40 ms MLEV-17 mixing period.
For fraction UTB a 2D HOHAHA spectrum (see Fig.  4 ) with a 40 ms mixing time was recorded in order to unambiguously establish the mannose H-l/H-2 connectivities. The pertinent 1H-NMR data of compound U7.2 match those obtained for an identical oligosaccharide structure released by endo-H from recombinant tissue plasminogen activator (cf. compound B1 in [23] ).
Fraction US. The 600-MHz ~H-NMR spectrum of fraction U8 indicates one compound, denoted U8 (spectrum not shown) The ~H-chemical-shift values of this compound match completely those obtained for an identical oligosaccharidestructure isolated from hen ovalbumin (cf. compound {M5} in [21] ). The structure of oligosaccharide U8 is Manel-3(Man 1-6)Man~l-6(Manc~l-3)Manfll-4GlcNAcfll-4GlcNAc.
Fraction U9. The elution position on HPLC suggests that fraction U9 contains oligosaccharides with the general formula ManTGlcNAc2. From the 500 MHz tH-NMR spectrum of fraction U9 three otigosaccharides can be identified, denoted U9.1, U9.2, and U9.3, respectively, having the following structures:
. The presence of the N,N'-diacetylchitobiose element at the reducing end is deduced from the characteristic set of GlcNAc-1 and -2 H-1 and NAc signals (see Table 2 ). The mannose structural-reporter-group signals for the mixture of oligosaccharides present in fraction U9 match those previously obtained for a mixture of three ManTGlcNAc 2-glycopeptides isolated from kidney bean glycoprotein II [24] .
Brain-derived oligosaccharides
The mixture of oligosaccharides isolated from the brain was separated by FPLC anion-exchange chromatography on Mono Q (not shown). Only the neutral peak turned out to contain carbohydrate material, and was subfractionated by HPLC into thirteen fractions on a Lichrosorb-NH 2 column (Fig. 5) . The carbohydrate positive fractions B7-B13 were further characterized by 1H-NMR spectroscopy. However, the amounts of material in B10, B12, and B13 were too low for structure determination by 1H-NMR spectroscopy, but the HPLC retention times suggest the following types of compounds: Man3GlcNAc 2 in B10, Man4GlcNAc2 in B12, and Man5GlcNAc in B13.
Fraction B7. Fraction B7 represents the major accumulated oligosaccharide in brain, accounting for 37~ of the total amount of oligosaccharides in the brain tissue. The structuralreporter-group regions of the 500-MHz IH-NMR spectrum of B7 are shown in Fig. 6 . Because the 1H-NMR structural reporters of fraction B7 match those of the urinary compound UI.I (see Table 1 ), B7 is identified as Manel-3Manfll-4GIcNAc. Fraction B8. The 1H-NMR spectrum (not shown) of fraction B8 shows that this fraction contains a single compound, whose structural-reporter groups match those of the urinary compound U2.2 (see Table 2 ). Thus, the structure of compound B8 is Manel-3Manfil-4GlcNAcfll-4GlcNAc.
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Fraction B9. The 500-MHz 1H-NMR spectrum (not shown) of fraction B9 indicates that it contains one compound, denoted B9. From the GlcNAc-2 H-lc~ and NAc signals it can be deduced that B9 contains a reducing GlcNAc-2. Two ~Man H-1 signals are present at c~ = 5.358 ppm (Man-4, 2-substituted) and at 6 = 5.050 ppm (Man-C, terminal), respectively, and therefore the structure of compound B9 is Manel-2Mancd-3ManB1-4GlcNAc. The IH-NMR structural-reporter groups of B9 match those obtained for an identical oligosaccharide structure isolated from human a-mannosidosis urine (cf. compound 64 in [17] ).
Fraction Bll. From the elution position on HPLC, the components of fraction Bll are predicted to have the general formula Man,GlcNAc. The 500-MHz 1H-NMR spectrum (not shown) indicates the presence in equimolar amounts of two compounds, namely: Manel-2Mancd-3(Man~l-6)Manfll-4GlcNAc (B11.1) and Mancd-2Mancd-2Manel-3Manfll-4GlcNAc (Bll.2). The presence of GlcNAc-2 at the reducing end is inferred from the GlcNAc-2 H-lc~ and NAc signals ( 
Discussion
This study describes the isolation and structure determination of 17 urinary and five brain-derived oligosaccharides from a Persian cat suffering from ~-mannosidosis. In Table 3 the structures of both the urinary and the brain-derived oligosaccharides are compiled, together with their relative amounts. For comparison, the oligosaccharides previously identified in human ~-mannosidosis urine [25, 25] , urine of swainsonineintoxicated sheep [20] , and feline ~.-mannosidosis urine and brain [10] are also included. The results obtained in this study for the urinary oligosaccharides are in close agreement with those reported by Abraham et al. [12] and by Warren et al. [10] . In addition to previously reported structures we have identified an additional structural isomer of MansGlcNAc (compound U7.2) which also occurs in low amounts in human ~-mannosidosis urine [25, 26] , two additional isomers of Man~GlcNAc 2 (compounds U6.2 and U6.3), and a new isomer of Man2GlcNAc, namely Manel3Manfll-4GlcNAc (compound UI.1). The trisaccharide UI.1 has the same structure as the major urinary oligosaccharide in human c~-mannosidosis [25] [26] [27] . However, in contrast to the chromatographic profiling studies by Warren et al. [1t3] , the accumulated oligosaccharides found in brain differ from those found in urine. In general, two main classes of oligosaccharides can be distinguished: one in which the oligosaccharides have a single N-acetylglucosamine residue at the reducing end (Man, GtcNAc-series), and another class to which oligosaccharides having an intact N,N'-diacetytchitobiose unit at the reducing end belong (Man, GlcNAc2-series ). In urine about 29% of the oligosaccharides belong to the Man, GlcNAc series and 7t% to the Man, GtcAc 2 series, whereas the corresponding values for the brain-derived otigosaccharides are 77% and 23%, respectively. Another significant difference between the brain-derived and the urinary otigosaccharides is the low amount of c~(1-6)-linked mannose residues in brain (5%) as compared to urine (99%). However, the exact cause of the different oligosaccharide patterns in urine and brain is still not clear. The patterns might not only reflect tissue differences in activity and specificity of residual c~-mannosidase(s) but also in N-glycoprotein glycan structures. Up to now the major accumulated oligosaccharides in dogs [28] , goats [29] , and cats [10] suffering from lysosomal diseases have been found to end in Manfll-4GlcNAcl~l-4GlcNAc, whereas the major accumulated oligosaccharides in man end in Man/?l-4GlcNAc [30] . Therefore, different catabolic routes have been proposed for the breakdown of N-glycoprotein glycans in man as compared to dogs, goats, and cats [11, 31, 32] . However, our recent finding of an intact N,N'-diacetylchitobiose unit in a sialyloligosaccharide from human galactosialidosis urine [33] and our findings in the present report, suggest the sequential action of an aspartylglucosaminidase (cleaving the GlcNAc-Asn linkage) and an endo-/~-N-acetylhexosaminidase (hydrolysing the GlcNAc/~I-4GlcNAc linkage) in both man and cat. Li et al. have isolated two kinds of endo-/%N-acetylhexosaminidases from human kidney [34] . One of the enzymes acts directly on oligomannose-type glycopeptides, while the other enzyme, Table 3 . Comparison of the structures of oligosaccharides isolated from feline ~-mannosidosis (e-man) urine and brain, human ~-mannosidosis urine, and ovine swainsonine toxicosis (OST) urine. For the shorthand symbolic notation, see Table t . This study [9] "
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